CleanFinder Brings Browser-Based Genome Editing Analysis to Labs without Coding

Why It Matters

By removing the need for bioinformatics expertise and ensuring data never leaves the user’s computer, CleanFinder lowers technical and privacy barriers, accelerating research and therapeutic development in genome editing.

Key Takeaways

• CleanFinder runs entirely in a web browser, no installation needed
• Analyzes CRISPR, base, prime, and mitochondrial edits
• Turbo mode screens 96‑ and 384‑well plates instantly
• Data never leaves user’s computer, preserving privacy
• Open‑source code available on GitHub for customization

Pulse Analysis

The rapid adoption of CRISPR and related editing tools has outpaced the availability of user‑friendly analysis software, leaving many labs dependent on specialized bioinformaticians. CleanFinder directly addresses this gap by delivering a point‑and‑click interface that processes raw sequencing data on the client side, eliminating the steep learning curve and costly software licenses that have traditionally limited broader adoption. Its ability to handle data from all major sequencing platforms ensures that researchers can move from experiment to insight without platform constraints.

At the heart of CleanFinder is a “glocal” alignment engine that simultaneously evaluates global sequence context and local edit signatures, delivering precise classification of insertions, deletions, base conversions, prime edits and even mitochondrial modifications. The platform’s Turbo mode accelerates high‑throughput screening of 96‑ and 384‑well plates, while an allelic‑dropout detector flags hidden loss‑of‑function events that could be misinterpreted as clean knockouts. Additional utilities—such as a built‑in genome viewer, donor‑oligo designer, and sequence‑conversion tools—streamline experiment planning, and a dependency‑free Python CLI mirrors the web engine for reproducible batch processing in larger pipelines.

Beyond technical convenience, CleanFinder’s client‑side processing safeguards sensitive patient or proprietary data, a critical consideration for clinical and commercial applications. The open‑source release on GitHub invites community contributions, fostering rapid iteration and integration with emerging editing modalities. As cell and gene therapies advance toward regulatory approval, tools that democratize data interpretation while maintaining privacy will become essential, positioning CleanFinder as a catalyst for faster, more inclusive innovation in the genome‑editing ecosystem.